THC Therapeutics, Inc.
CIK 1404935fmd_0V35726VP136F7DTWA0Z18QMKWManufacturing · Farm Machinery & EquipmentTemplate: Standard
Coverage: Aug 01, 2006 to Jul 31, 2024, 47 periods
Latest annual · FY2024
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (1)
- Net income
- (1)
Latest quarter · Q4 FY2024
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- n/m
- Revenue, 5 yearsFY2019 to FY2024
- n/m
- Net income, 5 yearsFY2019 to FY2024
- n/m
THC Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $0 | 10-K 2026-02-27 · proof | |
| Gross profit | $0 | $0 | 10-K 2026-02-27 · proof | |
| Operating income | -$541,975 | -$493,912 | 10-K 2026-02-27 · proof | |
| Net income | -$811,562 | -$387,036 | 10-K 2026-02-27 · proof | |
| Cash from operating activities | -$183,273 | -$85,432 | 10-K 2026-02-27 · proof | |
| Total assets | $10,648 | $12,990 | -18% | 10-K 2026-02-27 · proof |
| Total liabilities | $3.8 million | $3.3 million | +14.7% | 10-K 2026-02-27 · proof |
| Cash and cash equivalents | $35 | $10 | +250% | 10-K 2026-02-27 · proof |
- What was THC Therapeutics, Inc.'s revenue in fiscal 2024?
- THC Therapeutics, Inc. reported revenue of $0 for fiscal 2024 (the year ended Jul 31, 2024), against $0 the year before. Source: the 10-K filed with the SEC on Feb 27, 2026. SEC
- What was THC Therapeutics, Inc.'s gross profit in fiscal 2024?
- THC Therapeutics, Inc. reported gross profit of $0 for fiscal 2024 (the year ended Jul 31, 2024), against $0 the year before. Source: the 10-K filed with the SEC on Feb 27, 2026. SEC
- What was THC Therapeutics, Inc.'s operating income in fiscal 2024?
- THC Therapeutics, Inc. reported operating income of -$541,975 for fiscal 2024 (the year ended Jul 31, 2024), against -$493,912 the year before. Source: the 10-K filed with the SEC on Feb 27, 2026. SEC
- What was THC Therapeutics, Inc.'s net income in fiscal 2024?
- THC Therapeutics, Inc. reported net income of -$811,562 for fiscal 2024 (the year ended Jul 31, 2024), against -$387,036 the year before. Source: the 10-K filed with the SEC on Feb 27, 2026. SEC
- What was THC Therapeutics, Inc.'s cash from operating activities in fiscal 2024?
- THC Therapeutics, Inc. reported cash from operating activities of -$183,273 for fiscal 2024 (the year ended Jul 31, 2024), against -$85,432 the year before. Source: the 10-K filed with the SEC on Feb 27, 2026. SEC
- What are THC Therapeutics, Inc.'s total assets?
- As of Jul 31, 2024, THC Therapeutics, Inc. reported total assets of $10,648, against $12,990 a year earlier (-18%). Source: the 10-K filed with the SEC on Feb 27, 2026. SEC
- What are THC Therapeutics, Inc.'s total liabilities?
- As of Jul 31, 2024, THC Therapeutics, Inc. reported total liabilities of $3.8 million, against $3.3 million a year earlier (+14.7%). Source: the 10-K filed with the SEC on Feb 27, 2026. SEC
- What are THC Therapeutics, Inc.'s cash and cash equivalents?
- As of Jul 31, 2024, THC Therapeutics, Inc. reported cash and cash equivalents of $35, against $10 a year earlier (+250%). Source: the 10-K filed with the SEC on Feb 27, 2026. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1404935&period_type=annual&limit=5"Information only, not investment advice.